Schistosomiasis：グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Schistosomiasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Schistosomiasis Therapeutics Clinical Trials 25
Prominent Drug Comparison 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Dafra Pharma International Ltd. 27
Clinical Trial Overview of Dafra Pharma International Ltd. 27
Pharco Pharmaceuticals 28
Clinical Trial Overview of Pharco Pharmaceuticals 28
Clinical Trial Overview of Top Institutes / Government 29
DBL – Centre for Health Research and Development 29
Clinical Trial Overview of DBL – Centre for Health Research and Development 29
Swiss Tropical and Public Health Institute 30
Clinical Trial Overview of Swiss Tropical and Public Health Institute 30
The National Institute of Allergy and Infectious Diseases 31
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 31
Queensland Institute of Medical Research 32
Clinical Trial Overview of Queensland Institute of Medical Research 32
Catholic University of Health and Allied Sciences 33
Clinical Trial Overview of Catholic University of Health and Allied Sciences 33
Swiss Federal Institute of Technology 34
Clinical Trial Overview of Swiss Federal Institute of Technology 34
Navrongo Health Research Centre 35
Clinical Trial Overview of Navrongo Health Research Centre 35
University of Khartoum 36
Clinical Trial Overview of University of Khartoum 36
Addis Ababa University 37
Clinical Trial Overview of Addis Ababa University 37
Biomedical Primate Research Centre 38
Clinical Trial Overview of Biomedical Primate Research Centre 38
Universiteit Antwerpen 39
Clinical Trial Overview of Universiteit Antwerpen 39
Oslo University Hospital 40
Clinical Trial Overview of Oslo University Hospital 40
Hopital Albert Schweitzer 41
Clinical Trial Overview of Hopital Albert Schweitzer 41
Makerere University 42
Clinical Trial Overview of Makerere University 42
Oswaldo Cruz Foundation 43
Clinical Trial Overview of Oswaldo Cruz Foundation 43
Institut National de la Sante et de la Recherche Medicale 44
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 44
Aarhus University 45
Clinical Trial Overview of Aarhus University 45
Huazhong University of Science & Technology 46
Clinical Trial Overview of Huazhong University of Science & Technology 46
University Hospital, Lille 47
Clinical Trial Overview of University Hospital, Lille 47
The University of Edinburgh 48
Clinical Trial Overview of The University of Edinburgh 48
Five Key Clinical Profiles 49
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 74